Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced submission of the fourth and final module of the Pre-Market Approval (PMA) application to the ...

Allurion Technologies said patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage. The developer of obesity ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year.

Allurion Technologies has a fifty-two week low of $2.15 and a fifty-two week high of $98.75. The firm’s 50-day simple moving average is $4.01 and its two-hundred day simple moving average is $9.84.

Allurion Technologies Inc. (NYSE:ALUR) Q4 2024 Earnings Conference Call March 26, 2025 8:30 AM ETCompany ParticipantsMike Cavanaugh - Investor ...

Allurion Technologies ALUR shares are moving higher Friday, potentially in response to the company's Thursday announcement of a planned clinical study to evaluate the combination of its Allurion ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle mass and overall body composition.

NATICK, Mass., December 24, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that its Board of Directors has ...

Allurion Technologies, Inc., a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty five reverse stock split of the Company ...

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty ...